{"article_id": "CLW_q3_2021.txt", "article": ["on a consolidated basis , the company reported net sales of $ 450 million , adjusted net income of $ 9 million , and adjusted ebit of $ 50 million .", "and finally , we maintained ample liquidity of $ 270 million at quarter end and reduce net debt by another $ 7 million .", "since the beginning of this year , fastmarkets risi has reported price increases for the us market that totaled $ 250 per ton in folding carton and cardstock .", "this includes a $ 50 per ton increase in october for both grades .", "the financial impact from this outage to our adjusted ebitda was $ 5 million .", "in north america , we view tissue demand as being approximately 10 million tons with annual demand growth of 1 % to 2 % , slightly exceeding population growth .", "we ship 12.3 million cases in the third quarter , a 21 % increase from the 10.2 million cases shipped in the second quarter .", "this was a bit higher than our guidance of 10 % to 15 % growth , partly driven by the august demand uptick .", "in the third quarter 2021 , our net income was $ 2 million , diluted net income per share was $ 0.11 , and adjusted net income per share was $ 0.55 .", "the impact of the neenah closure activities in the quarter was $ 5.4 million , which was related to severance and related expenses .", "our costs were impacted by $ 5 million of major maintenance outage expenses , and higher inflation and maintenance expenses .", "our sales have converted products in the third quarter were 12.3 million cases representing a unit decline of 15 % versus prior year .", "our production of converted product in the quarter was 11.4 million cases are down 25 % versus the prior year .", "please note that we largely exited the away from home tissue segments in the third quarter of this year , which historically represented 3 % to 4 % of our overall case volume .", "slide 10 outlines our capital structure , our liquidity was $ 270 million at the end of the third quarter .", "during the third quarter , we reduced net debt by $ 7 million .", "we 've continued to target the net debt to adjusted ebitda ratio of 2.5 times , which we expect to achieve by 2023 .", "but that said , our expectation for the fourth quarter is adjusted ebitda of $ 48 million to $ 56 million .", "let me walk you through the build up to that range from our third quarter adjusted ebitda $ 50 million .", "previously announced sbs prices is expected to positively impact us during the quarter by $ 7 million to $ 9 million which is helping to offset inflation .", "raw material and freight cost inflation is expected to negatively impact us by $ 7 million to $ 12 million .", "there are no planned major maintenance outages , which will benefit us , given the $ 5 million q3 outage .", "we are expected to achieve the full run rate benefit of the neenah closure , which we previous previously stated as being more than $ 10 million annualized .", "if we take actuals for the first nine months and add our expectations for the first quarter , we expect adjusted ebitda of $ 167 million to $ 175 million for the full year 2021 .", "we are expecting continued positive impact from previously announced sps price increases , which are expected to result in year - over - year benefits of $ 53 million to $ 55 million .", "in our paper board business , planned major maintenance outages are expected to reduce our earnings for 2021 compared to 2020 by $ 27 million .", "our current view is that our tissue volume decline year - over - year will be above 20 % , which is not adjusted for the impact of our exit from the away - from - home business .", "in total , from 2020 to 2021 , input cost inflation , including pulp , packaging , energy , and chemicals , as well as freight is expected to be $ 80 million to $ 85 million relative to our previous estimate of $ 60 million to $ 70 million .", "in total , the benefit from the neenah closure is expected to exceed $ 10 million annually .", "interest expense between $ 36 million and $ 38 million ; depreciation and amortization between $ 104 million and $ 107 million ; capital expenditures of approximately $ 42 million and $ 47 million , which is lower than our prior expectations ; and historical average of around $ 60 million , excluding extraordinary projects , and our effective tax rate is expected to be 26 % to 27 % .", "private brand tissue share in the us rose to over 30 % recently , up from 18 % in 2011 .", "as mike mentioned earlier , with this plan , we will achieve our near - term target leverage ratio of 2.5 x by 2023 ."], "summary_gold": "compname posts q3 earnings per share of $ 0.11 .<q>q3 earnings per share $ 0.11 .<q>q3 adjusted non -gaap earnings per share $ 0.55 .<q>q3 revenue $ 450 million .", "summary_pred": "interest expense between $ 36 million and $ 38 million ; depreciation and amortization between $ 104 million and $ 107 million ; capital expenditures of approximately $ 42 million and $ 47 million , which is lower than our prior expectations ; and historical average of around $ 60 million , excluding extraordinary projects , and our effective tax rate is expected to be 26 % to 27 % .<q>as mike mentioned earlier , with this plan , we will achieve our near - term target leverage ratio of 2.5 x by 2023 .<q>private brand tissue share in the us rose to over 30 % recently , up from 18 % in 2011 .<q>there are no planned major maintenance outages , which will benefit us , given the $ 5 million q3 outage .<q>please note that we largely exited the away from home tissue segments in the third quarter of this year , which historically represented 3 % to 4 % of our overall case volume .<q>in north america , we view tissue demand as being approximately 10 million tons with annual demand growth of 1 % to 2 % , slightly exceeding population growth .<q>our production of converted product in the quarter was 11.4 million cases are down 25 % versus the prior year .<q>we are expected to achieve the full run rate benefit of the neenah closure , which we previous previously stated as being more than $ 10 million annualized .<q>this includes a $ 50 per ton increase in october for both grades .<q>let me walk you through the build up to that range from our third quarter adjusted ebitda $ 50 million .<q>this was a bit higher than our guidance of 10 % to 15 % growth , partly driven by the august demand uptick .<q>and finally , we maintained ample liquidity of $ 270 million at quarter end and reduce net debt by another $ 7 million .<q>but that said , our expectation for the fourth quarter is adjusted ebitda of $ 48 million to $ 56 million .", "len_article": 32, "len_summary_gold": 4, "len_summary_pred": 13, "len_sent_scores": 32}